Tarsus Pharmaceuticals (TARS) Short Interest Ratio & Short Volume → WARNING about the death of the U.S. dollar… (From Colonial Metals) (Ad) Free TARS Stock Alerts $34.35 -0.66 (-1.89%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Tarsus Pharmaceuticals Short Interest DataCurrent Short Interest7,470,000 sharesPrevious Short Interest7,660,000 sharesChange Vs. Previous Month-2.48%Dollar Volume Sold Short$287.60 millionShort Interest Ratio11.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares37,780,000 sharesPercentage of Shares Shorted19.77%Today's Trading Volume407,241 sharesAverage Trading Volume693,152 sharesToday's Volume Vs. Average59% Short Selling Tarsus Pharmaceuticals ? Sign up to receive the latest short interest report for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTARS Short Interest Over TimeTARS Days to Cover Over TimeTARS Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Tarsus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20247,470,000 shares $287.60 million -2.5%N/A11.1 $38.50 4/30/20247,660,000 shares $240.75 million -3.0%N/A10.7 $31.43 4/15/20247,900,000 shares $276.03 million +0.6%N/A10.7 $34.94 3/31/20247,850,000 shares $285.35 million +9.0%N/A10.1 $36.35 3/15/20247,200,000 shares $227.38 million +19.4%N/A9.3 $31.58 2/29/20246,030,000 shares $230.47 million +6.5%N/A7.5 $38.22 Get the Latest News and Ratings for TARS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20245,660,000 shares $178.57 million +4.2%N/A7.7 $31.55 1/31/20245,430,000 shares $147.91 million +8.2%N/A7.7 $27.24 1/15/20245,020,000 shares $110.94 million +0.4%N/A7.9 $22.10 12/31/20235,000,000 shares $101.25 million +1.8%N/A8.2 $20.25 12/15/20234,910,000 shares $93.54 million +10.3%N/A8.3 $19.05 11/30/20234,450,000 shares $73.56 million -0.2%N/A8.1 $16.53 11/15/20234,460,000 shares $79.97 million +6.2%N/A9.2 $17.93 10/31/20234,200,000 shares $59.81 million +5.0%N/A10.1 $14.24 10/15/20234,000,000 shares $51.92 million -19.4%N/A7.6 $12.98 9/30/20234,960,000 shares $88.14 million +13.0%N/A10.2 $17.77 9/15/20234,390,000 shares $70.85 million -2.7%N/A10.1 $16.14 8/31/20234,510,000 shares $78.97 million +0.7%N/A10.8 $17.51 8/15/20234,480,000 shares $76.16 million +17.9%N/A11.3 $17.00 7/31/20233,800,000 shares $83.64 million +65.9%N/A9.9 $22.01 7/15/20232,290,000 shares $40.42 million +2.2%13.0%10.7 $17.65 6/30/20232,240,000 shares $40.48 million +42.7%11.4%11 $18.07 6/15/20231,570,000 shares $29.23 million +72.6%8.0%7.8 $18.62 5/31/2023909,800 shares $15.24 million +6.8%4.7%5.5 $16.75 5/15/2023852,000 shares $14.11 million -11.3%4.4%6.2 $16.56 4/30/2023960,800 shares $14.34 million +0.2%5.0%8.7 $14.92 4/15/2023959,400 shares $11.10 million -3.3%5.0%9.3 $11.57 3/31/2023991,600 shares $12.46 million -4.7%5.2%12 $12.57 3/15/20231,040,000 shares $14.29 million +4.3%5.4%14.2 $13.74 2/28/2023996,700 shares $15.44 million +1.1%5.4%12 $15.49 2/15/2023985,900 shares $15.12 million +1.8%5.3%11.2 $15.34 1/31/2023968,800 shares $15.27 million -6.9%5.1%9.9 $15.76 1/15/20231,040,000 shares $15.12 million No Change5.5%9.7 $14.54 12/30/20221,040,000 shares $15.25 million +19.0%6.1%10.9 $14.66 12/15/2022874,300 shares $12.91 million -28.9%5.1%9.1 $14.77 11/30/20221,230,000 shares $20.68 million -3.2%7.2%12.8 $16.81 11/15/20221,270,000 shares $22.61 million -14.8%7.4%13.7 $17.80 10/31/20221,490,000 shares $27.45 million -0.7%8.9%16.6 $18.42 10/15/20221,500,000 shares $25.47 million +0.7%9.0%17.5 $16.98 9/30/20221,490,000 shares $25.51 million +19.2%8.9%17.4 $17.12This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry 9/15/20221,250,000 shares $19.96 million No Change7.5%11.1 $15.97 8/31/20221,250,000 shares $19.23 million No Change7.5%10.6 $15.38 8/15/20221,250,000 shares $22.99 million -1.6%7.5%8.6 $18.39 7/31/20221,270,000 shares $19.08 million -3.8%7.7%6.9 $15.02 7/15/20221,320,000 shares $19.34 million +8.2%8.0%5.6 $14.65 6/30/20221,220,000 shares $17.81 million +91.4%7.4%5.2 $14.60 6/15/2022637,400 shares $8.34 million +45.9%3.9%2.8 $13.09 5/31/2022437,000 shares $6.01 million +13.0%2.6%2.4 $13.75 5/15/2022386,800 shares $5.08 million -32.2%2.3%2.6 $13.13 4/30/2022570,200 shares $10.44 million -3.0%5.9%5.1 $18.31 4/15/2022587,800 shares $10.80 million +7.3%6.1%14 $18.38 3/31/2022548,000 shares $9.22 million +35.4%5.7%14.2 $16.82 3/15/2022404,600 shares $7.17 million +4.7%4.2%11.4 $17.71 2/28/2022386,400 shares $6.81 million +10.0%4.0%13.2 $17.63 2/15/2022351,200 shares $5.62 million +6.3%3.6%11.9 $16.00 1/31/2022330,300 shares $6.63 million +2.3%3.4%11.6 $20.07 1/15/2022322,900 shares $6.70 million -0.7%3.3%12.2 $20.75 12/31/2021325,200 shares $7.32 million 0.0%3.4%10.9 $22.50 12/15/2021325,300 shares $8.57 million +2.7%3.4%10.9 $26.34 11/30/2021316,700 shares $8.42 million +1.3%3.3%10.5 $26.60 11/15/2021312,600 shares $7.99 million -3.3%3.3%10.1 $25.56 10/29/2021323,100 shares $8.97 million -2.3%3.5%11.8 $27.76 10/15/2021330,800 shares $9.43 million +0.6%3.5%11 $28.52 9/30/2021329,000 shares $7.09 million +0.2%3.5%11.9 $21.55 9/15/2021328,400 shares $7.16 million +7.5%3.5%9.3 $21.81 8/31/2021305,400 shares $8.09 million -1.7%3.3%5.6 $26.50 8/13/2021310,800 shares $8.07 million -2.4%3.3%5.3 $25.98 7/30/2021318,500 shares $7.19 million -2.7%3.6%5 $22.57 7/15/2021327,200 shares $8.43 million +3.1%3.7%4.7 $25.76 6/30/2021317,500 shares $9.20 million +12.8%3.6%4.5 $28.98 6/15/2021281,400 shares $9.92 million -10.4%3.3%4.2 $35.26 5/28/2021314,000 shares $10.46 million -15.4%3.7%6.6 $33.32 5/14/2021371,100 shares $10.99 million -3.3%4.3%8.3 $29.62 4/30/2021383,600 shares $11.58 million +0.1%4.5%9.1 $30.20 4/15/2021383,400 shares $11.51 million -5.6%4.5%11.5 $30.01 3/31/2021406,300 shares $11.50 million +3.2%4.8%11.1 $28.30 3/15/2021393,800 shares $13.19 million +6.6%4.7%5.2 $33.50 2/26/2021369,400 shares $13.87 million +5.9%4.4%4.2 $37.56 2/12/2021348,800 shares $12.82 million +34.1%4.2%3.8 $36.76 1/29/2021260,200 shares $10.13 million +2.9%3.1%2.8 $38.92 1/15/2021253,000 shares $11.11 million No Change3.0%2.5 $43.91 TARS Short Interest - Frequently Asked Questions What is Tarsus Pharmaceuticals' current short interest? Short interest is the volume of Tarsus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 7,470,000 shares of TARS short. Learn More on Tarsus Pharmaceuticals' current short interest. What is a good short interest ratio for Tarsus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARS shares currently have a short interest ratio of 11.0. Learn More on Tarsus Pharmaceuticals's short interest ratio. Which institutional investors are shorting Tarsus Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tarsus Pharmaceuticals: StemPoint Capital LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Tarsus Pharmaceuticals' short interest increasing or decreasing? Tarsus Pharmaceuticals saw a decline in short interest in May. As of May 15th, there was short interest totaling 7,470,000 shares, a decline of 2.5% from the previous total of 7,660,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Tarsus Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Tarsus Pharmaceuticals: Vir Biotechnology, Inc. (6.99%), Neumora Therapeutics, Inc. (11.63%), BioCryst Pharmaceuticals, Inc. (16.64%), 4D Molecular Therapeutics, Inc. (18.67%), Ginkgo Bioworks Holdings, Inc. (19.74%), Inhibrx, Inc. (3.91%), Fusion Pharmaceuticals Inc. (3.60%), Autolus Therapeutics plc (1.22%), Sana Biotechnology, Inc. (21.23%), Relay Therapeutics, Inc. (8.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Tarsus Pharmaceuticals stock? Short selling TARS is an investing strategy that aims to generate trading profit from Tarsus Pharmaceuticals as its price is falling. TARS shares are trading down $0.66 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tarsus Pharmaceuticals? A short squeeze for Tarsus Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TARS, which in turn drives the price of the stock up even further. How often is Tarsus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARS, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Vir Biotechnology Short Interest Neumora Therapeutics Short Interest BioCryst Pharmaceuticals Short Interest 4D Molecular Therapeutics Short Interest Ginkgo Bioworks Short Interest Inhibrx Short Interest Fusion Pharmaceuticals Short Interest Autolus Therapeutics Short Interest Sana Biotechnology Short Interest Relay Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TARS) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.